Replies to post #143069 on NanoViricides Inc. (NNVC)

[arvitar]

Given it's been 15 years and almost $100M spent, and they still haven't pushed any of their cides through IND, the explanation for why they won't do it for coronavirus is probably a little simpler than this.

You know nothing if you think a "drug will be announced soon", particularly if by "drug" you mean something that could be used on humans anytime the Wuhan cold is still an issue. If (big "if") NNVC is even working on a 'cide for coronavirus it will be at least a month before they have a 'cide they'd want to test. Then they'd have to try in on some animal models for some time, and probably iterate for some time with improved versions of the 'cide. In a year, assuming maximum speed, they'd have something to put through pre-IND toxicity testing. A year after that they might have IND approval, and can start phase I tests, which might start at best 6 months later. Three years from now, assuming NNVC proceeds much faster than it ever has before, they might be done with phase I trials. It will be at least 2 years after that before they'd get through phase II and phase III trials and a 'cide approved for sale.
So 5 years total is an optimistic estimate, and Wuhan cold will be a note in the history books by then.